Dean Kereiakes, MD
Interventional Cardiology · Cincinnati, OHNPI 1427025055
Payments from drug & device makers
Across 941 payments — averaging $3623.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$1.2M
- Boston Scientific$793K
- Edwards Lifesciences$667K
- Amgen$239K
- Novo Nordisk AS$209K
- Novartis$143K
- plus $176K from 20 others
Across 2 payments — averaging $1524.60 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$3K
- Novo Nordisk AS$50
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 157 | $1,182,725 |
| Boston Scientific | 76 | $792,876 |
| Edwards Lifesciences | 220 | $666,903 |
| Amgen | 24 | $238,828 |
| Novo Nordisk AS | 242 | $208,824 |
| Novartis | 11 | $143,115 |
| Shockwave Medical, Inc | 49 | $98,961 |
| Biotronik Inc. | 98 | $27,091 |
| AstraZeneca | 2 | $13,619 |
| Merck | 4 | $11,800 |
| Sanofi US Services Inc. | 7 | $10,577 |
| Ancora Heart, Inc. | 17 | $5,083 |
| Lexicon Pharmaceuticals, Inc. | 1 | $3,449 |
| Abbott | 14 | $2,494 |
| Medicure Pharma Inc. | 1 | $1,500 |
| Amarin Pharma, Inc. | 3 | $774 |
| Bayer | 3 | $424 |
| Abiomed | 2 | $240 |
| Asahi Intecc USA, Inc. | 1 | $196 |
| Jenavalve Technology, Inc. | 1 | $122 |
| Lundbeck LLC | 2 | $44 |
| Regeneron Healthcare Solutions, Inc. | 1 | $12 |
| Chiesi USA, Inc. | 1 | $12 |
| Johnson & Johnson | 1 | $11 |
| Bardy Diagnostics, Inc. | 1 | $10 |
| Ablative Solutions, Inc. | 2 | $0 |
How this compares
$3,409,688 in reported general payments places this provider in the 95th percentile of 256 interventional cardiology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional cardiology in Cincinnati
- Santiago GarciaCincinnati$3.6M
- Joseph ChooCincinnati$1.9M
- Timothy HenryCincinnati$1.3M
- John CorlCincinnati$793K
- Ian SarembockCincinnati$266K
- Puvi SeshiahCincinnati$230K
- Steven RudickCincinnati$216K
- Imran ArifCincinnati$127K
- Jonathan RappCincinnati$91K
- Raviteja GuddetiCincinnati$68K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.